Market IntelliX Research indicates the global market for DPP-4 Inhibitor Innovative Drugs will achieve significant expansion, projecting growth from US$ 342 million in 2025 to an estimated US$ 469 million by 2031. This performance translates to a strong Compound Annual Growth Rate (CAGR) of 5.7% throughout the forecast period of 2025–2031.